Pharmacoinvasive Treatment of High-Risk Pulmonary Thromboembolism: A Case Report
Keywords:
pulmonary embolism; acute heart failure; shock; catheter-guide fibrinolysisAbstract
Pulmonary thromboembolism is defined as the sudden obstruction of the pulmonary circulation by an embolus originating from the venous system, most commonly from the lower extremities or the pelvic region. Its most severe form, high-risk pulmonary thromboembolism, presents with acute right ventricular failure, hypotension, or cardiogenic shock. It is among the top five causes of death worldwide. Immediate reperfusion measures, along with cardiovascular and respiratory life support, are required to prevent rapid hemodynamic deterioration and to improve patient survival. We present the case of a patient who arrived at the emergency department with a clinical presentation of acute right ventricular failure due to high-risk pulmonary thromboembolism, treated with a mechanical-pharmacological approach as an alternative to guideline-recommended therapy, resulting in successful recovery.
Downloads
References
1. Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res [Internet]. 2016;118(9):1340-7. DOI: https://doi.org/10.1161/CIRCRESAHA.115.306841
2. Keller K, Hobohm L, Ebner M, Kresoja KP, Munzel T, Konstantinides SV, et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J [Internet]. 2020;41(4):522-9. DOI: https://doi.org/10.1093/eurheartj/ehz236
3. Lehnert P, Lange T, Moller CH, Olsen PS, Carlsen J. Acute pulmonary embolism in a national Danish cohort: increasing incidence and decreasing mortality. Thromb Haemost [Internet]. 2018;118(3):539-46. DOI: https://doi.org/10.1160/TH17-08-0531
4. Gimena-Rodríguez FJ, Barba-Martín R, Angelina-García M, Trujillo-Luque D, Joya-Seijo MD, Rueda-Camino JA. Trends in pulmonary embolism incidence in Spain (2016-2022): an analysis of differences among autonomous communities. Rev Clin Esp [Internet]. 2025;225(9):502377. DOI: https://doi.org/10.1016/j.rce.2025.502377
5. Leidi A, Bex S, Righini M, Berner A, Grosgurin O, Marti C. Risk Stratification in Patients with Acute Pulmonary Embolism: Current Evidence and Perspectives. J Clin Med [Internet]. 2022;11(9): 2533. DOI: https://doi.org/10.3390/jcm11092533
6. Duffett L, Castellucci LA, Forgie MA. Pulmonary embolism: update on management and controversies. BMJ [Internet]. 2020;370:m2177. DOI: https://doi.org/10.1136/bmj.m2177
7. Kumbhani DJ, Cannon CP, Beavers CJ, Bhatt DL, Cuker A, Gluckmanet TJ, et al. 2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention or with atherosclerotic cardiovascular disease: a report of the American College of Cardiology Solution Set Oversight Committee. JACC [Internet]. 2021;77(5):629–58. DOI: https://doi.org/10.1016/j.jacc.2020.09.011
8. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersinget G, Harjola VP, et al. Guía ESC 2019 para el diagnóstico y tratamiento de la embolia pulmonar aguda. Rev Esp Cardiol [Internet]. 2020;73(6):497.e1–497.e58. DOI: https://doi.org/10.1016/j.recesp.2019.12.030
9. Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv [Internet]. 2020;4(19):4693-738. DOI: http://doi.org/10.1182/bloodadvances.2020001830
10. Creager MA, Barnes GD, Giri J, Mukherjee D, Jones WS, Burnett AE, et al. 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN guideline for the evaluation and management of acute pulmonary embolism in adults: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. JACC [Internet]. 2026;87(13):1626–1710. DOI: http://doi.org/10.1016/j.jacc.2025.11.005.
11. Aykan AC, Gökdeniz T, Gül I, Kalaycıoğlu E, Karabay CY, Boyacı F, et al. Reduced-dose systemic fibrinolysis in massive pulmonary embolism: a pilot study. Clin Exp Emerg Med [Internet]. 2023;10(3):280–6. DOI: http://doi.org/https://doi.org/10.15441/ceem.23.015
12. Sanchez O, Charles-Nelson A, Ageno W, Barco S, Binder H, Chatellier G, et al. Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial. Thromb Haemost [Internet]. 2022;122(5):857-66. DOI: http://doi.org/10.1055/a-1653-4699
13. Toma C, Bunte MC, Cho KH, Jaber WA, Chambers J, Stegman B, et al. Percutaneous mechanical thrombectomy in a real-world pulmonary embolism population: interim results of the FLASH registry. Catheter Cardiovasc Interv [Internet]. 2022;99(4):1345–55. DOI: https://doi.org/10.1002/ccd.30091
14. Kobayashi T, Pugliese S, Sethi SS, Parihk SA, Goldberg J, Alkhafan F, et al. Contemporary management and outcomes of patients with high-risk pulmonary embolism. J Am Coll Cardiol [Internet]. 2024;83(1):35–43. DOI: https://doi.org/10.1016/j.jacc.2023.10.026
15. Balakrishna AM, Kalathil RAM, Pusapati S, Atreya A, Mehta A, Bansal M, et al. Comparative outcomes of catheter-directed thrombolysis plus systemic anticoagulation versus systemic anticoagulation alone in the management of intermediate-risk pulmonary embolism in a systematic review and meta-analysis. Am J Cardiol [Internet]. 2023;205:249–58. DOI: https://doi.org/10.1016/j.amjcard.2023.07.170
16. Seropian IM, Rojas CAM, Damonte JI, Chiabrando JG, Bluro IM, Berrocal DH. Estudio unicéntrico del tratamiento con trombolíticos dirigidos por catéter en el tromboembolismo pulmonar agudo. Medicina (B. Aires) [Internet]. 2021 [citado 20 Feb 2026];81(3):382-8. Available from: https://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802021000300382&lng=es.
17. Aguilar CG. Trombólisis dirigida por catéter para el manejo del tromboembolismo pulmonar, en el servicio de radiología e imágenes. 2020-2022. Panamá. RMC-UNACHI [Internet]. 2025;2(1):42-9. DOI: https://doi.org/10.59722/rmcu.v2i1.850
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Sergio Estrada Gómez, Geovedy Martínez García, Huber García Herrera, María de Lourdes Luna Díaz
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
